Stock Quote

Former U.S. Senator Mike Gravel to Head up Marijuana Company

Cannabis Sativa, Inc. (OTCQB:CBDS) announced the reorganization of its wholly owned subsidiary, KUSH, as a separate strategic business unit with former United States Senator Mike Gravel at the helm. KUSH will focus on the development and marketing of innovative new cannabis products for the recreational and medicinal markets including a proprietary lozenge called the “Kubby.”

Senator Mike Gravel (Photo: Business Wire)

Senator Mike Gravel (Photo: Business Wire)

Senator Gravel served as the U.S. Senator for Alaska from 1969 to 1981 and has been an outspoken critic of the failed “War on Drugs” since the Nixon era.

Steve Kubby, well-known medical marijuana pioneer and current Chairman of the Board for Cannabis Sativa, Inc., proclaimed: “Senator Gravel stood up to Nixon, stood up to the Pentagon, and now he is standing up to those in power who would keep the healthful benefits of cannabis from those who need them. He’s been a director of KUSH since its inception and brings invaluable perspective and connections to our group. He’s a true American hero and we’re excited to have him serving in this capacity.”

Senator Gravel stated: “I’m anxious to assist in bringing this important resource to a broader market in a serious and credible way.”

Senator Gravel served on the Finance, Interior, Environmental and Public Works committees, and chaired the Energy, Water Resources, Buildings and Grounds and Environmental Pollution subcommittees. Senator Gravel is best known for forcing an end to the military draft with a five-month filibuster and challenging the U.S. Government by releasing the Pentagon Papers. When the Nixon administration interrupted the New York Times, Washington Post and other newspapers from publishing with prior restraint injunctions, Senator Gravel stepped up to place the documents into the official Senate Record and facilitated their public distribution. Gravel has written several books, one of which, Citizen Power, devotes an entire chapter debunking the “War on Drugs.” A respected cannabis advocate, Senator Gravel has personally benefited from its medicinal use.

About CBDS

Cannabis Sativa, Inc. is engaged through its recently acquired subsidiary, KUSH, in the research, development, patenting and licensing of specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. CBDS also offers the Skin Garden line of cosmetic products through its subsidiary, Wild Earth Naturals, which are designed to use organic and natural ingredients, including hemp seed oil, to benefit inner wellbeing as well as outward appearance.

Forward-Looking Statements

This press release contains "forward-looking statements." Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements.

Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Contacts:

KUSH
Michael Pickens, 209-402-7440
Executive V.P./COO
cmichaelpickens@gmail.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.